Search

everythinglearnresearchcommunity

for

Search:↓

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Genetic mutations that disrupt homocysteine breakdown lead to increased damage in mouse hair keratin.

Antiandrogen treatment can reduce sexual enjoyment in women with excess male hormones, especially those in stable relationships.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

A new genetic mutation causes severe Leydig cell hypoplasia, affecting sexual development.

Finasteride crystals are held together by hydrogen bonds and weak interactions, forming synthon pseudopolymorphs.

Amino acids in conditioners improve hair strength, hydration, and color retention.

Polyamines are abundant in certain parts of rat hair follicles and may play a key role in hair growth.

An 11-year-old Greek girl was diagnosed with a rare genetic disorder, highlighting the importance of genetic testing and family history.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Aromoline and DRD4 are potential targets for osteoarthritis treatment.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Adults with classic congenital adrenal hyperplasia value medication that prevents weight gain from glucocorticoids the most.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Two new compounds were found to effectively reduce hair growth in mice.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Cyproterone acetate is an effective treatment for women with acne, hair loss, and excessive hair growth.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

The compounds tested could potentially treat hair loss and alopecia.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

The research found enzymes in Stephania epigaea that help make cepharanthine.

H+-ATPase is crucial for plant growth and can be influenced by microbial compounds, affecting root hair development.